Cargando…
Can we vaccinate against Type 1 diabetes?
Vaccination is the administration of antigenic material to stimulate the immune system to develop adaptive immunity to a disease. As the most successful prophylactic in medical history, there is now an emerging interest as to whether vaccination can be applied in autoimmune and inflammatory conditio...
Autor principal: | Peakman, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463895/ https://www.ncbi.nlm.nih.gov/pubmed/23112807 http://dx.doi.org/10.3410/B4-19 |
Ejemplares similares
-
Regulatory T cell dysfunction in type 1 diabetes: what’s broken and how can we fix it?
por: Hull, Caroline M., et al.
Publicado: (2017) -
Peptide Immunotherapy for Type 1 Diabetes—Clinical Advances
por: Smith, Emma L., et al.
Publicado: (2018) -
Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010) -
Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?
por: Abdulameer, Shaymaa Abdalwahed, et al.
Publicado: (2012) -
Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options
por: Cieluch, Aleksandra, et al.
Publicado: (2020)